{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:01:53Z","timestamp":1760043713197},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.01.014","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T09:52:38Z","timestamp":1235469158000},"page":"108-114","source":"Crossref","is-referenced-by-count":10,"title":["A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteers"],"prefix":"10.1016","volume":"31","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Hellriegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.01.014_bib1","first-page":"671","article-title":"Low back pain","volume":"81","author":"Ehrlich","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clinthera.2009.01.014_bib2","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archinte.161.13.1613","article-title":"Cyclobenzapnne and back pain: A meta-analysis","volume":"161","author":"Browning","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.014_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society\/American College of Physicians clinical practice guideline","volume":"147","author":"Chou","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.014_bib4","doi-asserted-by":"crossref","first-page":"21282156","DOI":"10.1097\/00007632-199709150-00012","article-title":"Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions","volume":"22","author":"van Tulder","year":"1997","journal-title":"Spine"},{"key":"10.1016\/j.clinthera.2009.01.014_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0091270002042001007","article-title":"Cyclobenzapnne pharmacokinetics, including the effects of age, gender, and hepatic insufficiency","volume":"42","author":"Winchell","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.014_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0149-2918(03)80067-X","article-title":"Efficacy of a low-dose regimen of cyclobenzapnne hydrochloride in acute skeletal muscle spasm: Results of two placebo-controlled trials","volume":"25","author":"Borenstein","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.01.014_bib7","first-page":"409","article-title":"Cyclobenzapnne, diazepam and placebo in the treatment of skeletal muscle spasm of local origin","volume":"1","author":"Nibbelink","year":"1978","journal-title":"Clin Their"},{"key":"10.1016\/j.clinthera.2009.01.014_bib8","first-page":"216","article-title":"Cyclobenzapnne in the treatment of acute muscle spasm: Review of a decade of clinical experience","volume":"10","author":"Katz","year":"1988","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.01.014_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1139\/y81-007","article-title":"Cyclobenzapnne: A possible mechanism of action for its muscle relaxant effect","volume":"59","author":"Commissiong","year":"1981","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.014_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0028-3908(75)90091-X","article-title":"Cyclobenzapnne: Novel centrally acting skeletal muscle relaxant","volume":"14","author":"Share","year":"1975","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2009.01.014_bib11","series-title":"Amrix [package insert]","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.014_bib12","first-page":"134","article-title":"Efficacy of cyclobenzapnne hydrochloride extended-release 15 mgand 30 mg once-daily for low back and neck pain associated with muscle spasms: A pooled analysis of two randomized, double-blind, parallel-group, placebo-controlled, multicenter studies","volume":"9","author":"Weil","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.clinthera.2009.01.014_bib13","first-page":"592","article-title":"Overview of patient compliance with medication dosing: A literature review","volume":"6","author":"Greenberg","year":"1984","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2009.01.014_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MJT.0b013e31802b59e4","article-title":"Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population","volume":"14","author":"Stang","year":"2007","journal-title":"Am J Ther"},{"key":"10.1016\/j.clinthera.2009.01.014_bib15","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1185\/030079907X219643","article-title":"Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: Comparison of extended-release oxycodone and OROS hydromorphone","volume":"23","author":"Ward","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2009.01.014_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/0044011-200828120-00007","article-title":"Single-dose pharmacokinetics of once-daily cyclobenzapnne extended release 30 mg versus cyclobenzapnne immediate release 10 mg three times daily in healthy young adults. A randomized, open-label, two-period crossover, single-centre study","volume":"28","author":"Darwish","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2009.01.014_bib18","year":"1996","journal-title":"ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1)"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T08:23:20Z","timestamp":1545380600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0149291809000289"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.01.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}